Health TrialsbyHealthPanel

Feasibility of Internet-based HIV Prevention Research

ConditionsHIV PreventionInjection Drug Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMontefiore Medical Center

About this trial

The study will use social media to recruit a diverse sample of people who self-report injecting drugs, assessing the feasibility of online assessments and participants' ability to perform at-home self-administered HIV testing. Participants will complete online questionnaires at baseline and will be mailed HIV testing kits that they will self-administer and mail to a central laboratory. Investigators will track completion of questionnaires and whether at-home self-administered HIV tests were completed and sent to the laboratory.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years or older

US residency

English or Spanish fluency

injection drug use (self-report, past 30 days)

Disqualifiers

HIV status known to be positive

Trial design

Design model

Single group

Treatments tested in this trial

  • Mail delivery of at-home self-administered HIV tests

    Diagnostic test

    Investigators will mail participants an OraSure HIV-1 Oral Specimen Collection Device. The kit will include a self-addressed and stamped envelope with the collection device. Participants will follow enclosed directions to collect oral-fluid samples and mail them to the study laboratory for analysis. Envelopes and samples will only be marked with a bar code and not with any other personal identifiers (e.g., name or address).

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: At-home self-administered HIV testingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

HIV test completion

This outcome will be the percentage of enrolled participants that have valid HIV testing results. The numerator will be the number of HIV test kits collected properly and sent to the laboratory for testing successfully. The denominator will be the total number of enrolled participants.

Time frame
12 months

Secondary outcomes

1

Screening feasibility

This outcome will measure the percentage of potential participants who complete enrollment. The numerator will be the number of participants that complete screening questionnaires and provide informed consent. The denominator will be the total number of potential participants that click on study advertisement or link to the study.

Time frame
Baseline
2

Feasibility of study procedures

This outcome will be the percentage of enrolled participants that complete baseline questionnaires and mail in HIV testing kits to the laboratory. The numerator will be the number of HIV test kits received at the laboratory and the denominator will be the total number of enrolled participants.

Time frame
12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Montefiore Medical Center

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov
Apply now